BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu R, Li X, Zhu W, Wang Y, Zhao D, Wang X, Gurley EC, Liang G, Chen W, Lai G, Pandak WM, Robert Lippman H, Bajaj JS, Hylemon PB, Zhou H. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis. Hepatology 2019;70:1317-35. [PMID: 30985008 DOI: 10.1002/hep.30662] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 25.7] [Reference Citation Analysis]
Number Citing Articles
1 Niu Q, Wang T, Wang Z, Wang F, Huang D, Sun H, Liu H. Adipose-derived mesenchymal stem cell-secreted extracellular vesicles alleviate non-alcoholic fatty liver disease via delivering miR-223-3p. Adipocyte 2022;11:572-87. [PMID: 36093813 DOI: 10.1080/21623945.2022.2098583] [Reference Citation Analysis]
2 Xie D, Qian B, Li X. Nucleic acids and proteins carried by exosomes from various sources: Potential role in liver diseases. Front Physiol 2022;13:957036. [DOI: 10.3389/fphys.2022.957036] [Reference Citation Analysis]
3 Lin C, Xing J, Jiang Z, Sun L, Gao Y, Yang S, Wang D, Yin N. Tanshinone IIA Inhibits Liver Fibrosis by Regulating COL1A1 Expression Through H19 / let-7a in Mice. Natural Product Communications 2022;17:1934578X2211236. [DOI: 10.1177/1934578x221123698] [Reference Citation Analysis]
4 Kong W, Zhang L, Chen Y, Yu Z, Zhao Z. Cancer cell-derived exosomal LINC00313 induces M2 macrophage differentiation in non-small cell lung cancer. Clin Transl Oncol 2022. [PMID: 35980503 DOI: 10.1007/s12094-022-02907-7] [Reference Citation Analysis]
5 Marrero E, Attal N, Nimeri A, McGee RM, Benbow JH, Thompson KJ, Schrum LW, McKillop IH. Ectodysplasin-A mRNA in exosomes released from activated hepatic stellate cells stimulates macrophage response. Exp Cell Res 2022;419:113297. [PMID: 35964664 DOI: 10.1016/j.yexcr.2022.113297] [Reference Citation Analysis]
6 Wang J, Yuan Z, Zhang H, Wu Q, Miao Y, Xu Y, Yu Q, Huang X, Zhang Z, Huang X, Tang Q, Zhang L, Jiang Z. Obeticholic acid aggravates liver injury by up-regulating the liver expression of osteopontin in obstructive cholestasis. Life Sci 2022;307:120882. [PMID: 35963300 DOI: 10.1016/j.lfs.2022.120882] [Reference Citation Analysis]
7 Zhang Y, Jiao Z, Chen M, Shen B, Shuai Z. Roles of Non-Coding RNAs in Primary Biliary Cholangitis. Front Mol Biosci 2022;9:915993. [DOI: 10.3389/fmolb.2022.915993] [Reference Citation Analysis]
8 Li L, Bi Y, Diao S, Li X, Yuan T, Xu T, Huang C, Li J. Exosomal LncRNAs and Hepatocellular Carcinoma: From Basic Research to Clinical Practice. Biochem Pharmacol 2022;:115032. [PMID: 35395241 DOI: 10.1016/j.bcp.2022.115032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wu B, Tian X, Wang W, Zhu J, Lu Y, Du J, Xiao Y. Upregulation of cadherin‐11 contributes to cholestatic liver fibrosis. Pediatric Investigation. [DOI: 10.1002/ped4.12317] [Reference Citation Analysis]
10 Li YJ, Liu RP, Ding MN, Zheng Q, Wu JZ, Xue XY, Gu YQ, Ma BN, Cai YJ, Li S, Lin S, Zhang LY, Li X. Tetramethylpyrazine prevents liver fibrotic injury in mice by targeting hepatocyte-derived and mitochondrial DNA-enriched extracellular vesicles. Acta Pharmacol Sin 2022. [PMID: 35027662 DOI: 10.1038/s41401-021-00843-w] [Reference Citation Analysis]
11 Trauner M, Fuchs CD. Novel therapeutic targets for cholestatic and fatty liver disease. Gut 2022;71:194-209. [PMID: 34615727 DOI: 10.1136/gutjnl-2021-324305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
12 Ding W, Wang H, Zhang Y. Recent insights into the pathogeneses and therapeutic targets of liver diseases: Summary of the 4th Chinese American Liver Society/Society of Chinese Bioscientists in America Hepatology Division Symposium in 2021. Liver Research 2022. [DOI: 10.1016/j.livres.2022.01.002] [Reference Citation Analysis]
13 Wang Z, Yang X, Gui S, Yang F, Cao Z, Cheng R, Xia X, Li C. The Roles and Mechanisms of lncRNAs in Liver Fibrosis. Front Pharmacol 2021;12:779606. [PMID: 34899344 DOI: 10.3389/fphar.2021.779606] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Li Y, Liu P, Wei F. Long non‑coding RNA MBI‑52 inhibits the development of liver fibrosis by regulating the microRNA‑466g/SMAD4 signaling pathway. Mol Med Rep 2022;25:33. [PMID: 34850963 DOI: 10.3892/mmr.2021.12549] [Reference Citation Analysis]
15 Zhang J, Liu Q, He J, Li Y. Novel Therapeutic Targets in Liver Fibrosis. Front Mol Biosci 2021;8:766855. [PMID: 34805276 DOI: 10.3389/fmolb.2021.766855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Xiong J, Wu L, Huang L, Wu C, Liu Z, Deng W, Ma S, Zhou Z, Yu H, Cao K. LncRNA FOXP4-AS1 Promotes Progression of Ewing Sarcoma and Is Associated With Immune Infiltrates. Front Oncol 2021;11:718876. [PMID: 34765540 DOI: 10.3389/fonc.2021.718876] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
17 Xue X, Wu J, Ding M, Gao F, Zhou F, Xu B, Lu M, Li J, Li X. Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis. Chin Med 2021;16:112. [PMID: 34736501 DOI: 10.1186/s13020-021-00524-0] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
18 Li X, Ge J, Li Y, Cai Y, Zheng Q, Huang N, Gu Y, Han Q, Li Y, Sun R, Liu R. Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease. Acta Pharm Sin B 2021;11:3527-41. [PMID: 34900534 DOI: 10.1016/j.apsb.2021.03.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
19 Chen Y, Zhao Y, Yin Y, Jia X, Mao L. Mechanism of cargo sorting into small extracellular vesicles. Bioengineered 2021;12:8186-201. [PMID: 34661500 DOI: 10.1080/21655979.2021.1977767] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
20 Zhuo Z, Wang J, Luo Y, Zeng R, Zhang C, Zhou W, Guo K, Wu H, Sha W, Chen H. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles. Acta Biomater 2021;134:13-31. [PMID: 34284151 DOI: 10.1016/j.actbio.2021.07.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
21 Ezhilarasan D. Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis. J Cell Physiol 2021. [PMID: 34514599 DOI: 10.1002/jcp.30582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
22 Wang Y, Hylemon PB, Zhou H. Long Noncoding RNA H19: A Key Player in Liver Diseases. Hepatology 2021;74:1652-9. [PMID: 33630308 DOI: 10.1002/hep.31765] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
23 Di Mauro S, Salomone F, Scamporrino A, Filippello A, Morisco F, Guido M, Lembo V, Cossiga V, Pipitone RM, Grimaudo S, Malaguarnera R, Purrello F, Piro S. Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD. Nutrients 2021;13:2952. [PMID: 34578828 DOI: 10.3390/nu13092952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Xia S, Wang Z, Chen L, Zhou Y, Li Y, Wang S, Chen A, Xu X, Shao J, Zhang Z, Tan S, Zhang F, Zheng S. Dihydroartemisinin regulates lipid droplet metabolism in hepatic stellate cells by inhibiting lncRNA-H19-induced AMPK signal. Biochem Pharmacol 2021;192:114730. [PMID: 34400125 DOI: 10.1016/j.bcp.2021.114730] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Su W, Huo Q, Wu H, Wang L, Ding X, Liang L, Zhou L, Zhao Y, Dan J, Zhang H. The function of LncRNA-H19 in cardiac hypertrophy. Cell Biosci 2021;11:153. [PMID: 34344446 DOI: 10.1186/s13578-021-00668-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Kostallari E, Valainathan S, Biquard L, Shah VH, Rautou PE. Role of extracellular vesicles in liver diseases and their therapeutic potential. Adv Drug Deliv Rev 2021;175:113816. [PMID: 34087329 DOI: 10.1016/j.addr.2021.05.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
27 Wang C, Deng J, Deng H, Kang Z, Huang Z, Ding Z, Dong L, Chen J, Zhang J, Zang Y. A Novel Sox9/lncRNA H19 Axis Contributes to Hepatocyte Death and Liver Fibrosis. Toxicol Sci 2020;177:214-25. [PMID: 32579217 DOI: 10.1093/toxsci/kfaa097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
28 Wang W, Li F, Lai X, Liu H, Wu S, Han Y, Shen Y. Exosomes secreted by palmitic acid-treated hepatocytes promote LX-2 cell activation by transferring miRNA-107. Cell Death Discov 2021;7:174. [PMID: 34234100 DOI: 10.1038/s41420-021-00536-7] [Reference Citation Analysis]
29 Sato K, Baiocchi L, Kennedy L, Zhang W, Ekser B, Glaser S, Francis H, Alpini G. Current Advances in Basic and Translational Research of Cholangiocarcinoma. Cancers (Basel) 2021;13:3307. [PMID: 34282753 DOI: 10.3390/cancers13133307] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Shi CX, Wang Y, Jiao FZ, Chen Q, Cao P, Pei MH, Zhang LY, Guo J, Deng W, Wang LW, Gong ZJ. Epigenetic Regulation of Hepatic Stellate Cell Activation and Macrophage in Chronic Liver Inflammation. Front Physiol 2021;12:683526. [PMID: 34276405 DOI: 10.3389/fphys.2021.683526] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Brigstock DR. Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics. Cells 2021;10:1596. [PMID: 34202136 DOI: 10.3390/cells10071596] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
32 Tian X, Wang Y, Lu Y, Wang W, Du J, Chen S, Zhou H, Cai W, Xiao Y. Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19. Cell Death Dis 2021;12:646. [PMID: 34168124 DOI: 10.1038/s41419-021-03931-1] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
33 Hernández-Aguilar AI, Luciano-Villa CA, Tello-Flores VA, Beltrán-Anaya FO, Zubillaga-Guerrero MI, Flores-Alfaro E. Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved : a systematic review. Expert Rev Mol Diagn 2021;21:809-21. [PMID: 34133256 DOI: 10.1080/14737159.2021.1944808] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Di Dato F, Ranucci G, de Ville de Goyet J, Alberti D, Iorio R. Unusual Clinical Course for Untreated Malformative Biliary Atresia Infant: Is Portal Hypertension an Important Driver of Liver Fibrosis? J Pediatr Gastroenterol Nutr 2021;72:216-9. [PMID: 32925558 DOI: 10.1097/MPG.0000000000002932] [Reference Citation Analysis]
35 Benbow JH, Marrero E, McGee RM, Brandon-Warner E, Attal N, Feilen NA, Culberson CR, McKillop IH, Schrum LW. Hepatic stellate cell-derived exosomes modulate macrophage inflammatory response. Exp Cell Res 2021;405:112663. [PMID: 34051242 DOI: 10.1016/j.yexcr.2021.112663] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
36 Wu JZ, Li YJ, Huang GR, Xu B, Zhou F, Liu RP, Gao F, Ge JD, Cai YJ, Zheng Q, Li XJ. Mechanisms exploration of Angelicae Sinensis Radix and Ligusticum Chuanxiong Rhizoma herb-pair for liver fibrosis prevention based on network pharmacology and experimental pharmacologylogy. Chin J Nat Med 2021;19:241-54. [PMID: 33875165 DOI: 10.1016/S1875-5364(21)60026-2] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
37 Xin Y, Li J, Wu W, Liu X. Mitofusin-2: A New Mediator of Pathological Cell Proliferation. Front Cell Dev Biol 2021;9:647631. [PMID: 33869201 DOI: 10.3389/fcell.2021.647631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
38 Wu J, Nagy LE, Wang L. The long and the small collide: LncRNAs and small heterodimer partner (SHP) in liver disease. Mol Cell Endocrinol 2021;528:111262. [PMID: 33781837 DOI: 10.1016/j.mce.2021.111262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Xia Y, Zhen L, Li H, Wang S, Chen S, Wang C, Yang X. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway. Cell Death Dis 2021;12:326. [PMID: 33771969 DOI: 10.1038/s41419-021-03494-1] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
40 Li Y, Liu F, Cai Y, Yang Y, Wang Y. LncRNA MALAT1: A Potential Fibrosis Biomarker and Therapeutic Target. Crystals 2021;11:249. [DOI: 10.3390/cryst11030249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Lin J, Luo Z, Liu S, Chen Q, Liu S, Chen J. Long non-coding RNA H19 promotes myoblast fibrogenesis via regulating the miR-20a-5p-Tgfbr2 axis. Clin Exp Pharmacol Physiol 2021;48:921-31. [PMID: 33615521 DOI: 10.1111/1440-1681.13489] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
42 Chen J, Zhang J, Gao Y, Li Y, Feng C, Song C, Ning Z, Zhou X, Zhao J, Feng M, Zhang Y, Wei L, Pan Q, Jiang Y, Qian F, Han J, Yang Y, Wang Q, Li C. LncSEA: a platform for long non-coding RNA related sets and enrichment analysis. Nucleic Acids Res 2021;49:D969-80. [PMID: 33045741 DOI: 10.1093/nar/gkaa806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
43 Ma Y, Harris J, Li P, Cao H. Long noncoding RNAs-a new dimension in the molecular architecture of the bile acid/FXR pathway. Mol Cell Endocrinol 2021;525:111191. [PMID: 33539963 DOI: 10.1016/j.mce.2021.111191] [Reference Citation Analysis]
44 Ganguly N, Chakrabarti S. Role of long non‑coding RNAs and related epigenetic mechanisms in liver fibrosis (Review). Int J Mol Med 2021;47:23. [PMID: 33495817 DOI: 10.3892/ijmm.2021.4856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
45 Wang Y, Tai YL, Zhao D, Zhang Y, Yan J, Kakiyama G, Wang X, Gurley EC, Liu J, Liu J, Liu J, Lai G, Hylemon PB, Pandak WM, Chen W, Zhou H. Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways. Cells 2021;10:210. [PMID: 33494295 DOI: 10.3390/cells10020210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
46 Zhang J, Ma Y, Xie D, Bao Y, Yang W, Wang H, Jiang H, Han H, Dong T. Differentially expressed lncRNAs in liver tissues of TX mice with hepatolenticular degeneration. Sci Rep 2021;11:1377. [PMID: 33446761 DOI: 10.1038/s41598-020-80635-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
47 Han S, Qi Y, Luo Y, Chen X, Liang H. Exosomal Long Non-Coding RNA: Interaction Between Cancer Cells and Non-Cancer Cells. Front Oncol 2020;10:617837. [PMID: 33520726 DOI: 10.3389/fonc.2020.617837] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
48 Yao Y, Jiao D, Li Z, Zhou X, Li J, Liu Z, Han X. Roles of Bile-Derived Exosomes in Hepatobiliary Disease. Biomed Res Int 2021;2021:8743409. [PMID: 33511212 DOI: 10.1155/2021/8743409] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Zhuo C, Yi T, Pu J, Cen X, Zhou Y, Feng S, Wei C, Chen P, Wang W, Bao C, Wang J, Tang Q. Exosomal linc-FAM138B from cancer cells alleviates hepatocellular carcinoma progression via regulating miR-765. Aging (Albany NY) 2020;12:26236-47. [PMID: 33401249 DOI: 10.18632/aging.202430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
50 Claveria-Cabello A, Colyn L, Uriarte I, Latasa MU, Arechederra M, Herranz JM, Alvarez L, Urman JM, Martinez-Chantar ML, Banales JM, Sangro B, Rombouts K, Oyarzabal J, Marin JJG, Berasain C, Avila MA, Fernandez-Barrena MG. Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis. Cancers (Basel) 2020;12:E3748. [PMID: 33322158 DOI: 10.3390/cancers12123748] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Lecerf C, Peperstraete E, Le Bourhis X, Adriaenssens E. Propagation and Maintenance of Cancer Stem Cells: A Major Influence of the Long Non-Coding RNA H19. Cells 2020;9:E2613. [PMID: 33291403 DOI: 10.3390/cells9122613] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
52 Jiao Y, Xu P, Shi H, Chen D, Shi H. Advances on liver cell-derived exosomes in liver diseases. J Cell Mol Med 2021;25:15-26. [PMID: 33247543 DOI: 10.1111/jcmm.16123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
53 Miao H, Wu XQ, Zhang DD, Wang YN, Guo Y, Li P, Xiong Q, Zhao YY. Deciphering the cellular mechanisms underlying fibrosis-associated diseases and therapeutic avenues. Pharmacol Res 2021;163:105316. [PMID: 33248198 DOI: 10.1016/j.phrs.2020.105316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
54 Shao J, Zaro J, Shen Y. Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate. Int J Nanomedicine 2020;15:9355-71. [PMID: 33262592 DOI: 10.2147/IJN.S281890] [Cited by in Crossref: 8] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
55 Yang Z, Zhang T, Han S, Kusumanchi P, Huda N, Jiang Y, Liangpunsakul S. Long noncoding RNA H19 - a new player in the pathogenesis of liver diseases. Transl Res 2021;230:139-50. [PMID: 33227504 DOI: 10.1016/j.trsl.2020.11.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
56 Yang Y, Deng X, Li Q, Wang F, Miao L, Jiang Q. Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges. Cancer Commun (Lond) 2020;40:655-80. [PMID: 33142045 DOI: 10.1002/cac2.12109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
57 Xie C, Li SY, Fang JH, Zhu Y, Yang JE. Functional long non-coding RNAs in hepatocellular carcinoma. Cancer Lett 2021;500:281-91. [PMID: 33129957 DOI: 10.1016/j.canlet.2020.10.042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
58 Claveria-Cabello A, Colyn L, Arechederra M, Urman JM, Berasain C, Avila MA, Fernandez-Barrena MG. Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target? Cells 2020;9:E2321. [PMID: 33086678 DOI: 10.3390/cells9102321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
59 Bu FT, Wang A, Zhu Y, You HM, Zhang YF, Meng XM, Huang C, Li J. LncRNA NEAT1: Shedding light on mechanisms and opportunities in liver diseases. Liver Int 2020;40:2612-26. [PMID: 32745314 DOI: 10.1111/liv.14629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
60 Khodayari N, Oshins R, Holliday LS, Clark V, Xiao Q, Marek G, Mehrad B, Brantly M. Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargo. Cell Commun Signal 2020;18:140. [PMID: 32887613 DOI: 10.1186/s12964-020-00648-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
61 Li X, Liu R. Long non-coding RNA H19 in the liver-gut axis: A diagnostic marker and therapeutic target for liver diseases. Experimental and Molecular Pathology 2020;115:104472. [DOI: 10.1016/j.yexmp.2020.104472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
62 Yang D, Liu J. Targeting extracellular vesicles-mediated hepatic inflammation as a therapeutic strategy in liver diseases. Liver Int 2020;40:2064-73. [PMID: 32593200 DOI: 10.1111/liv.14579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
63 Li Y, Liu R, Wu J, Li X. Self-eating: friend or foe? The emerging role of autophagy in fibrotic diseases. Theranostics 2020;10:7993-8017. [PMID: 32724454 DOI: 10.7150/thno.47826] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
64 Li M, Jiang M, Meng J, Tao L. Exosomes: Carriers of Pro-Fibrotic Signals and Therapeutic Targets in Fibrosis. Curr Pharm Des 2019;25:4496-509. [PMID: 31814552 DOI: 10.2174/1381612825666191209161443] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
65 Zhan C, Xiao G, Zhang X, Chen X, Zhang Z, Liu J. Decreased MiR-30a promotes TGF-β1-mediated arachnoid fibrosis in post-hemorrhagic hydrocephalus. Transl Neurosci 2020;11:60-74. [PMID: 33335750 DOI: 10.1515/tnsci-2020-0010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
66 Wang Z, Yang X, Kai J, Wang F, Wang Z, Shao J, Tan S, Chen A, Zhang F, Wang S, Zhang Z, Zheng S. HIF-1α-upregulated lncRNA-H19 regulates lipid droplet metabolism through the AMPKα pathway in hepatic stellate cells. Life Sci 2020;255:117818. [PMID: 32445757 DOI: 10.1016/j.lfs.2020.117818] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
67 Wang ZM, Xia SW, Zhang T, Wang ZY, Yang X, Kai J, Cheng XD, Shao JJ, Tan SZ, Chen AP, Wang SJ, Zhang F, Zhang ZL, Zheng SZ. LncRNA-H19 induces hepatic stellate cell activation via upregulating alcohol dehydrogenase III-mediated retinoic acid signals. Int Immunopharmacol 2020;84:106470. [PMID: 32304991 DOI: 10.1016/j.intimp.2020.106470] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
68 Jia Y, Jin H, Gao L, Yang X, Wang F, Ding H, Chen A, Tan S, Zhang F, Shao J, Wang S, Zheng S. A novel lncRNA PLK4 up-regulated by talazoparib represses hepatocellular carcinoma progression by promoting YAP-mediated cell senescence. J Cell Mol Med 2020;24:5304-16. [PMID: 32243714 DOI: 10.1111/jcmm.15186] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
69 Sato K, Meng F, Francis H, Wu N, Chen L, Kennedy L, Zhou T, Franchitto A, Onori P, Gaudio E, Glaser S, Alpini G. Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies. J Pineal Res 2020;68:e12639. [PMID: 32061110 DOI: 10.1111/jpi.12639] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
70 Sato K, Glaser S, Alvaro D, Meng F, Francis H, Alpini G. Cholangiocarcinoma: novel therapeutic targets. Expert Opin Ther Targets. 2020;24:345-357. [PMID: 32077341 DOI: 10.1080/14728222.2020.1733528] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
71 He Z, Yang D, Fan X, Zhang M, Li Y, Gu X, Yang M. The Roles and Mechanisms of lncRNAs in Liver Fibrosis. Int J Mol Sci 2020;21:E1482. [PMID: 32098245 DOI: 10.3390/ijms21041482] [Cited by in Crossref: 11] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
72 Sato K, Glaser S, Francis H, Alpini G. Concise Review: Functional Roles and Therapeutic Potentials of Long Non-coding RNAs in Cholangiopathies. Front Med (Lausanne) 2020;7:48. [PMID: 32154257 DOI: 10.3389/fmed.2020.00048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
73 Zhang K, Shi Z, Zhang M, Dong X, Zheng L, Li G, Han X, Yao Z, Han T, Hong W. Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis. Cell Death Dis. 2020;11:132. [PMID: 32071306 DOI: 10.1038/s41419-020-2323-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
74 Chen H, Xia W, Hou M. LncRNA-NEAT1 from the competing endogenous RNA network promotes cardioprotective efficacy of mesenchymal stem cell-derived exosomes induced by macrophage migration inhibitory factor via the miR-142-3p/FOXO1 signaling pathway. Stem Cell Res Ther 2020;11:31. [PMID: 31964409 DOI: 10.1186/s13287-020-1556-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
75 Li X, Liu R, Wang Y, Zhu W, Zhao D, Wang X, Yang H, Gurley EC, Chen W, Hylemon PB, Zhou H. Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions. Cells 2020;9:E190. [PMID: 31940841 DOI: 10.3390/cells9010190] [Cited by in Crossref: 23] [Cited by in F6Publishing: 39] [Article Influence: 11.5] [Reference Citation Analysis]
76 Yu TX, Chung HK, Xiao L, Piao JJ, Lan S, Jaladanki SK, Turner DJ, Raufman JP, Gorospe M, Wang JY. Long Noncoding RNA H19 Impairs the Intestinal Barrier by Suppressing Autophagy and Lowering Paneth and Goblet Cell Function. Cell Mol Gastroenterol Hepatol 2020;9:611-25. [PMID: 31862317 DOI: 10.1016/j.jcmgh.2019.12.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
77 Zhao W, Qin P, Zhang D, Cui X, Gao J, Yu Z, Chai Y, Wang J, Li J. Long non-coding RNA PVT1 encapsulated in bone marrow mesenchymal stem cell-derived exosomes promotes osteosarcoma growth and metastasis by stabilizing ERG and sponging miR-183-5p. Aging (Albany NY) 2019;11:9581-96. [PMID: 31699956 DOI: 10.18632/aging.102406] [Cited by in Crossref: 27] [Cited by in F6Publishing: 43] [Article Influence: 9.0] [Reference Citation Analysis]
78 Xiao Y, Liu R, Li X, Gurley EC, Hylemon PB, Lu Y, Zhou H, Cai W. Long Noncoding RNA H19 Contributes to Cholangiocyte Proliferation and Cholestatic Liver Fibrosis in Biliary Atresia. Hepatology 2019;70:1658-73. [PMID: 31063660 DOI: 10.1002/hep.30698] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 16.7] [Reference Citation Analysis]
79 Zhang K, Zhang M, Yao Q, Han X, Zhao Y, Zheng L, Li G, Liu Q, Chang Y, Zhang P, Cui H, Shi Z, Chen T, Yao Z, Han T, Hong W. The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition. Theranostics 2019;9:7566-82. [PMID: 31695787 DOI: 10.7150/thno.36942] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
80 Meurer S, Wimmer AE, Leur EV, Weiskirchen R. Endoglin Trafficking/Exosomal Targeting in Liver Cells Depends on N-Glycosylation. Cells 2019;8:E997. [PMID: 31466384 DOI: 10.3390/cells8090997] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
81 Zhang Z, Qiao J, Zhang D, Zhu W, Zhu J, Leng X, Li S. Noncoding RNAs Act as Tumor-Derived Molecular Components in Inducing Premetastatic Niche Formation. Biomed Res Int 2019;2019:9258075. [PMID: 31309120 DOI: 10.1155/2019/9258075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]